Publications & Works

Articles Published in Journals That Entered SCI, SSCI and AHCI Indexes

Agmatine-attenuated cognitive and social deficits in subchronic MK-801 model of schizophrenia in rats

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, vol.28, no.3, pp.245-253, 2018 (Journal Indexed in SCI) Creative Commons License identifier identifier

Neuroinflammation in Schizophrenia: A Critical Review and The Future

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.26, no.4, pp.429-437, 2016 (Journal Indexed in SCI) Creative Commons License Sustainable Development identifier identifier

Regulation of GSK-3 Activity as A Shared Mechanism in Psychiatric Disorders

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.24, no.1, pp.97-108, 2014 (Journal Indexed in SCI) Creative Commons License identifier identifier

pK(a) Constant of Varenicline

JOURNAL OF CHEMICAL AND ENGINEERING DATA, vol.57, no.1, pp.14-17, 2012 (Journal Indexed in SCI) identifier identifier

Articles Published in Other Journals

Vortioxetine improved social and cognitive deficits in acute ketamine model of schizophrenia in rats

Journal of Research in Pharmacy, vol.24, no.8, pp.1-8, 2020 (Journal Indexed in ESCI)

Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats

Psyciatry and Behavioral Sciences, vol.10, no.2, pp.45-54, 2020 (Journal Indexed in ESCI)

Deneysel Şizofreni Modelleri: Psikofarmakolojik Bakış

Türkiye Klinikleri Laboratuvar Hayvanları Dergisi, vol.1, pp.105-114, 2017 (Other Refereed National Journals)

POSSIBLE PROTECTIVE EFFECTS OF AGMATINE ANDFAMOTIDINE ON MK-801-INDUCED CYTOTOXICITY IN SHSY 5YCELL LINE

Journal of Cellular Neuroscience and oxidative stess, 2017 (Refereed Journals of Other Institutions)

The involvement of Akt and GSK 3 Two pathways two pathology

Journal of Marmara University Institute of Health Sciences, pp.1, 2014 (Refereed Journals of Other Institutions) Creative Commons License

Refereed Congress / Symposium Publications in Proceedings

SIÇANLARDA SUBKRONİK MK-801 UYGULAMASININKORKU KOŞULLAMA UZERİNE ETKİLERİNİNİNCELENMESİ

1.UluslararasıSağlık Bilimleri ve İnovasyon Kongresi, 10 - 12 April 2020

Nigella sativa oil improved cognitive symptoms in subchronic MK-801 model of schizophrenia in rats

11th International Congress on Psychopharmacology 7th International Symposium on Child and Adolescent Psychopharmacology, 18 - 21 April 2019

Alpha-7 nicotinic acethylcholine receptor positive allosteric modulators improved GABAergic deficits of schizophrenia in subchronic MK-801 model of rats

10th International Congress on Psychopharmacology and 6th International Symposium on Child and Adolescent Psychopharmacology, 25 - 29 April 2018

Cholinergic alpha 7 nicotinic receptor agonism improved cognitive and negative symptoms of MK-801-induced schizophrenia in rats.

9th International Congress on Psychopharmacology and 5th International Symposium on Child and Adolescent Psychopharmacology, 26 - 30 April 2017

Olanzapine Reversed MK-801 Induced Cell Damage via Akt/GSK-3 β/β –Catenine Signaling Pathway in SH SY5Y Cell Culture

9th International Congress on Psychopharmacology and 5th International Symposium on Child and Adolescent Psychopharmacology, 26 - 30 April 2017, vol.27, pp.57

Famotidine: Is it a potential new candidate for the treatment of schizophrenia by inhibiting GSK-3 beta?

29th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Vienna, Austria, 17 - 20 September 2016, vol.26 identifier

Antidepressant like effect of hydro alcoholic extract of nigella sativa in tail suspension test in mice

29th Congress European College of Neuropsychophamacology (ECNP), Vienna, Austria, 17 - 20 September 2016 identifier

The combination of sub effective doses of agmatine and ketamine reduces obsessive compulsive like behavior of mice in marble burying test

30th World International College of Neuropsychopharmacology (CINP) Congress, Seoul, South Korea, 3 - 05 July 2016, vol.19, pp.24-25 identifier

Possible protective effects of agmatine and famotidine on MK 801 induced cytotoxicity in SHSY 5Y cell line

6th World Congress of Oxidative Stress, Calcium Signaling and TRP Channels, Isparta, Turkey, 24 - 27 May 2016

Famotidine reverses learning and memory deficits induced by acute ketamine model of schizophrenia in novel object recognition test in rats

8th International Congress on Psychopharmacology and 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Turkey, 20 - 24 April 2016

Agmatine potentiates the antidepressant effect of ketamine in forced swimming test of rats

8th International Congress on Psychopharmacology and 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Turkey, 20 - 24 April 2016

Agmatine treatment prevents MK 801 induced neurodegeneration in cell culture

8th International Congress on Psychopharmacology and 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Turkey, 20 - 24 April 2016

Possible neuroprotective effects of agmatine via GSK3 protein expression in SH SY5Y cell line

8th International Congress on Psychopharmacology and 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Turkey, 20 - 24 April 2016

Agmatine attenuates cecal ligation induced sickness behavior in rats

4th World Psychiatric Association International Congress, 18 - 22 November 2015, pp.446

The effect of acute ketamine administration on NLRP3 inflammasome activation in a sub chronic stress model of rats

28th European Congress of Neuropsychopharmacology (ECNP), Amsterdam, Netherlands, 29 August - 01 September 2015, vol.25, pp.226-227 identifier

Acute administration of ketamine inhibited stress induced pro inflammatory cytokines in hippocampus of rats

7th International Congress on Psychopharmacology and 3rd International Symposium on Child and Adolescent Psychopharmacology, Antalya, Turkey, 15 - 19 April 2015

Acute P2X7 receptor blockade by Brillant Blue G (BBG) does not result in antidepressant-like activity in rats

6th International Congress on Psychopharmacology and 2rd Symposium on Child and Adolescent Psychopharmacology, 16 - 20 April 2014